ARGNF:OTCMKTS
argenx SE
US$790,15
0,00%
(0,00) 1D
13 ຕ.ລ., 10 ໂມງ 39 ນາທີ 58 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGNF...
Mkt. cap
53,14 ຕື້
Avg. vol.
14,00
Volume
0,00
52-wk high
US$1.020,00
52-wk low
US$708,72
Beta
0,46
Shares outstanding
62,89 ລ້ານ
No. of employees
2 ພັນ
Mkt. cap
53,14 ຕື້
Avg. vol.
14,00
Volume
0,00
52-wk high
US$1.020,00
52-wk low
US$708,72
Beta
0,46
Shares outstanding
62,89 ລ້ານ
No. of employees
2 ພັນ
News stories
From web sources and news partners
Investing.com
·
5 ຊົ່ວໂມງກ່ອນ
Argenx shares may move 5.5% on earnings release next week
ad-hoc-news.de
·
15 ຊົ່ວໂມງກ່ອນ
Wells Fargo sets USD 1,356 target for argenx stock
TipRanks
·
18 ຊົ່ວໂມງກ່ອນ
argenx Schedules Q3 2026 Results Call and Business Update
www.marketscreener.com
·
19 ຊົ່ວໂມງກ່ອນ
Argenx to Report Third Quarter 2026 Financial Results and Business Update on October 22, 2026
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE